Jemincare Announces the Exclusive License of the Kras Inhibitor to HUYABIO
Jemincare, a leading pharmaceutical company from China, announced today its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., had licensed exclusive worldwide ex-China…